Aflac
Price data unavailable
Track AFL in your trading journalAbout Aflac
When researching Aflac, analysts typically begin with its Financials sector positioning and Life & Health Insurance industry dynamics. Aflac Inc offers supplemental health insurance and life insurance in the United States and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accident, dental and vision, disability, and long-term-care insurance. It markets its products through independent distributors, selling the majority of its policies directly to consumers at their places of work, and also reaches out to its customers outside of their worksite through digital mediums. The company has two reportable business segments: Aflac Japan, which generates the maximum revenue, and Aflac U.S.
The company reports trailing twelve-month revenue of $4.35B and net income of $1.02B. Key metrics include a return on equity of 3.4%, a debt-to-equity ratio of 2.88.
FINOTAUR provides free research summaries, news aggregation, and fundamentals for AFL to support both active traders and long-term investors.
Fundamentals
| Revenue (TTM) | $4.35B |
| Net Income (TTM) | $1.02B |
| EPS (TTM) | — |
| P/E Ratio | — |
| Return on Equity | 3.40% |
| Debt-to-Equity | 2.88 |
| Dividend per Share | — |
Recent News
- Investing.com·Apr 1
Cash Hoarding Signals Contrarian Window for This Dividend Grower
- GlobeNewswire Inc.·Mar 19
Ushur Launches Voice-Guided Experience for Synchronized Voice and Visual Customer Interactions in Regulated Industries
- Investing.com·Feb 24
The Robots Are Coming for Insurance and Paying Us 8.3% Dividends, Too
Want real-time analysis on AFL?
Track it free in your trading journal. Log trades, tag setups, and review your edge.